HRP950217B1 - Novel erythromycin derivatives, method for preparing the same and use thereof as drugs - Google Patents

Novel erythromycin derivatives, method for preparing the same and use thereof as drugs

Info

Publication number
HRP950217B1
HRP950217B1 HR950217A HRP950217A HRP950217B1 HR P950217 B1 HRP950217 B1 HR P950217B1 HR 950217 A HR950217 A HR 950217A HR P950217 A HRP950217 A HR P950217A HR P950217 B1 HRP950217 B1 HR P950217B1
Authority
HR
Croatia
Prior art keywords
drugs
preparing
same
erythromycin derivatives
novel erythromycin
Prior art date
Application number
HR950217A
Other languages
English (en)
Inventor
Constantin Agouridas
Yannick Benedetti
Jean-Francois Chantot
Alexis Denis
Odile Le Martret
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of HRP950217A2 publication Critical patent/HRP950217A2/hr
Publication of HRP950217B1 publication Critical patent/HRP950217B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HR950217A 1994-04-08 1995-04-07 Novel erythromycin derivatives, method for preparing the same and use thereof as drugs HRP950217B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9404154A FR2718450B1 (fr) 1994-04-08 1994-04-08 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Publications (2)

Publication Number Publication Date
HRP950217A2 HRP950217A2 (en) 1997-08-31
HRP950217B1 true HRP950217B1 (en) 2004-06-30

Family

ID=9461886

Family Applications (1)

Application Number Title Priority Date Filing Date
HR950217A HRP950217B1 (en) 1994-04-08 1995-04-07 Novel erythromycin derivatives, method for preparing the same and use thereof as drugs

Country Status (49)

Country Link
US (2) US5656607A (cg-RX-API-DMAC7.html)
EP (1) EP0676409B1 (cg-RX-API-DMAC7.html)
JP (1) JP3000023B2 (cg-RX-API-DMAC7.html)
KR (1) KR100317148B1 (cg-RX-API-DMAC7.html)
CN (1) CN1059445C (cg-RX-API-DMAC7.html)
AP (1) AP587A (cg-RX-API-DMAC7.html)
AT (1) ATE234853T1 (cg-RX-API-DMAC7.html)
AU (1) AU684939B2 (cg-RX-API-DMAC7.html)
BG (1) BG61916B1 (cg-RX-API-DMAC7.html)
BR (1) BR9506147A (cg-RX-API-DMAC7.html)
CA (1) CA2164638C (cg-RX-API-DMAC7.html)
CO (1) CO4370097A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ296005B6 (cg-RX-API-DMAC7.html)
DE (1) DE69529934T2 (cg-RX-API-DMAC7.html)
DK (1) DK0676409T3 (cg-RX-API-DMAC7.html)
DZ (1) DZ1869A1 (cg-RX-API-DMAC7.html)
EE (1) EE04498B1 (cg-RX-API-DMAC7.html)
ES (1) ES2189820T3 (cg-RX-API-DMAC7.html)
FI (1) FI111264B (cg-RX-API-DMAC7.html)
FR (1) FR2718450B1 (cg-RX-API-DMAC7.html)
GB (1) GB2288174A (cg-RX-API-DMAC7.html)
GE (1) GEP19991836B (cg-RX-API-DMAC7.html)
HR (1) HRP950217B1 (cg-RX-API-DMAC7.html)
HU (1) HU215396B (cg-RX-API-DMAC7.html)
IL (1) IL112954A (cg-RX-API-DMAC7.html)
IS (1) IS1865B (cg-RX-API-DMAC7.html)
JO (1) JO1850B1 (cg-RX-API-DMAC7.html)
LV (1) LV11182B (cg-RX-API-DMAC7.html)
MA (1) MA23501A1 (cg-RX-API-DMAC7.html)
MD (1) MD663G2 (cg-RX-API-DMAC7.html)
MY (1) MY114672A (cg-RX-API-DMAC7.html)
NO (1) NO308361B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ284498A (cg-RX-API-DMAC7.html)
OA (1) OA10200A (cg-RX-API-DMAC7.html)
PE (1) PE2896A1 (cg-RX-API-DMAC7.html)
PL (1) PL180837B1 (cg-RX-API-DMAC7.html)
PT (1) PT676409E (cg-RX-API-DMAC7.html)
RO (1) RO115634B1 (cg-RX-API-DMAC7.html)
RU (1) RU2141965C1 (cg-RX-API-DMAC7.html)
SA (1) SA97170757A (cg-RX-API-DMAC7.html)
SI (1) SI0676409T1 (cg-RX-API-DMAC7.html)
SK (1) SK284079B6 (cg-RX-API-DMAC7.html)
SV (1) SV1995000018A (cg-RX-API-DMAC7.html)
TN (1) TNSN95026A1 (cg-RX-API-DMAC7.html)
TW (1) TW316908B (cg-RX-API-DMAC7.html)
UA (1) UA44705C2 (cg-RX-API-DMAC7.html)
WO (1) WO1995027720A1 (cg-RX-API-DMAC7.html)
YU (1) YU49221B (cg-RX-API-DMAC7.html)
ZA (1) ZA952059B (cg-RX-API-DMAC7.html)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745289B1 (fr) * 1996-02-28 1998-05-29 Roussel Uclaf Nouveaux derives de l'acide 1(2h) quinoleine carboxylique, leur procede de preparation et leur application a la synthese de produits doues de proprietes antibiotiques
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
DE69723848T2 (de) * 1996-05-07 2004-07-01 Abbott Laboratories, Abbott Park 3-descladinose-2,3-anhydroerythromycin-derivate
FR2748746B1 (fr) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
FR2751656B1 (fr) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
IL128681A0 (en) * 1996-09-04 2000-01-31 Abbott Lab 6-O substituted ketolides having antibacterial activity
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
WO1998040392A1 (fr) * 1997-03-10 1998-09-17 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
AU6421398A (en) * 1997-03-24 1998-10-20 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU6932098A (en) * 1997-05-09 1998-12-08 Pfizer Products Inc. Erythromycin derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
EP0988308A1 (en) * 1997-06-11 2000-03-29 Pfizer Products Inc. 9-oxime erythromycin derivatives
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
EP1115732B1 (en) 1998-09-22 2005-06-29 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
EP1749832A3 (en) * 1998-12-10 2008-03-26 Pfizer Products Incorporated Carbamate and carbazate ketolide antibiotics
ATE344269T1 (de) 1998-12-10 2006-11-15 Pfizer Prod Inc Carbamat und carbazat ketolid antibiotika
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
FR2789392B1 (fr) 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
AU773678B2 (en) * 1999-04-16 2004-06-03 Kosan Biosciences, Inc. Macrolide antiinfective agents
AU4354900A (en) 1999-04-16 2000-11-02 Kosan Biosciences, Inc. Ketolide antibacterials
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
OA11945A (en) * 1999-05-24 2006-04-13 Pfizer Prod Inc 13-Methyl erythromycin derivatives.
EP1404693A2 (en) * 2001-07-03 2004-04-07 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
CN105039464A (zh) 2002-07-01 2015-11-11 阿基昂生命科学公司,以生物技术资源部的名义经营 用于生产葡糖胺和n-乙酰氨基葡糖的方法和物质
WO2004080391A2 (en) 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
WO2004096822A2 (en) * 2003-04-25 2004-11-11 Chiron Corporation Pyridyl substituted ketolide antibiotics
WO2004096823A2 (en) * 2003-04-25 2004-11-11 Chiron Corporation Novel ketolide derivatives
JP5698979B2 (ja) 2007-10-25 2015-04-08 センプラ ファーマシューティカルズ,インコーポレイテッド マクロライド系抗菌剤の調製プロセス
HRP20160222T1 (hr) * 2008-10-24 2016-04-08 Cempra Pharmaceuticals, Inc. Biozaštite uporabom makrolida koji sadrže triazol
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
WO2011032052A1 (en) 2009-09-10 2011-03-17 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
KR102006200B1 (ko) 2010-03-22 2019-08-01 셈프라 파마슈티컬스, 인크. 매크로라이드의 결정 형태들 및 그 용도들
EP2571506B1 (en) 2010-05-20 2017-05-10 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
EP2968801B1 (en) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法
AU2014248014B2 (en) 2013-04-04 2018-11-08 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
JP2017531663A (ja) 2014-10-08 2017-10-26 プレジデント アンド フェローズ オブ ハーバード カレッジ 14員ケトライドならびにそれらの調製および使用の方法
EP3273969A4 (en) 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides with modified desosamine sugars and uses thereof
MD1222Z (ro) * 2017-05-31 2018-08-31 ИНСТИТУТ ЭЛЕКТРОННОЙ ИНЖЕНЕРИИ И НАНОТЕХНОЛОГИЙ "D. Ghitu" АНМ Procedeu de tratare a materialului săditor al florilor înainte de plantare
JP7199722B2 (ja) 2019-12-25 2023-01-06 旭精工株式会社 硬貨搬送振分機構及びそれを備えた硬貨識別搬送装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868414A (en) * 1973-01-22 1975-02-25 Merck & Co Inc Tetrahydrofluorene carboxylic acids and related compounds
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2842759A1 (de) * 1978-09-30 1980-04-10 Merck Patent Gmbh Basische aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
AU684939B2 (en) 1998-01-08
IL112954A0 (en) 1995-06-29
SV1995000018A (es) 1997-10-24
TW316908B (cg-RX-API-DMAC7.html) 1997-10-01
MD663F1 (ro) 1997-01-31
MD663G2 (ro) 1997-07-31
BG61916B1 (bg) 1998-09-30
NO954942L (no) 1996-02-07
YU49221B (sh) 2004-11-25
RO115634B1 (ro) 2000-04-28
DZ1869A1 (fr) 2002-02-17
KR100317148B1 (ko) 2002-06-22
EE9500080A (et) 1996-12-16
HRP950217A2 (en) 1997-08-31
SK154695A3 (en) 1996-10-02
US5656607A (en) 1997-08-12
AU2310795A (en) 1995-10-30
CN1126997A (zh) 1996-07-17
EE04498B1 (et) 2005-06-15
AP9500743A0 (en) 1995-07-31
DK0676409T3 (da) 2003-06-23
YU21695A (sh) 1997-12-05
LV11182B (en) 1997-04-20
PE2896A1 (es) 1996-02-12
PL180837B1 (pl) 2001-04-30
DE69529934T2 (de) 2003-09-04
PT676409E (pt) 2003-08-29
FR2718450A1 (fr) 1995-10-13
IS4309A (is) 1995-11-17
CA2164638C (fr) 2003-12-30
IL112954A (en) 2000-07-16
GB2288174A (en) 1995-10-11
CZ322395A3 (en) 1996-08-14
IS1865B (is) 2003-05-02
NO308361B1 (no) 2000-09-04
DE69529934D1 (de) 2003-04-24
HU215396B (hu) 1998-12-28
JP3000023B2 (ja) 2000-01-17
CO4370097A1 (es) 1996-10-07
ES2189820T3 (es) 2003-07-16
LV11182A (lv) 1996-04-20
GB9506856D0 (en) 1995-05-24
SI0676409T1 (en) 2003-06-30
HU9503505D0 (en) 1996-02-28
SK284079B6 (sk) 2004-09-08
NZ284498A (en) 1997-07-27
UA44705C2 (uk) 2002-03-15
ZA952059B (en) 1996-03-13
FI955913A7 (fi) 1995-12-08
RU2141965C1 (ru) 1999-11-27
CA2164638A1 (fr) 1995-10-19
AP587A (en) 1997-04-29
BR9506147A (pt) 1996-04-16
OA10200A (fr) 1996-12-18
GEP19991836B (en) 1999-11-05
FR2718450B1 (fr) 1997-01-10
NO954942D0 (no) 1995-12-06
MY114672A (en) 2002-12-31
MA23501A1 (fr) 1995-12-31
PL311871A1 (en) 1996-03-18
US5760233A (en) 1998-06-02
ATE234853T1 (de) 2003-04-15
HUT73772A (en) 1996-09-30
BG100150A (bg) 1996-06-28
CZ296005B6 (cs) 2005-12-14
FI111264B (fi) 2003-06-30
CN1059445C (zh) 2000-12-13
TNSN95026A1 (fr) 1996-02-06
WO1995027720A1 (fr) 1995-10-19
FI955913A0 (fi) 1995-12-08
EP0676409A1 (fr) 1995-10-11
JPH07278177A (ja) 1995-10-24
EP0676409B1 (fr) 2003-03-19
JO1850B1 (en) 1995-12-27
SA97170757A (ar) 2005-12-03

Similar Documents

Publication Publication Date Title
HRP950217B1 (en) Novel erythromycin derivatives, method for preparing the same and use thereof as drugs
HU9603038D0 (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
HUP9902576A3 (en) Novel erythromycin derivatives, method for preparing them, and use thereof as drugs
HUP0001115A3 (en) Heterocyclylmethyl-substituted pyrazol derivatives, process for their preparation and pharmaceuticals containing the same
HUP0000658A3 (en) Sulphonamide derivatives, process for their preparation, and their use as medicaments
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
HUP9601652A1 (en) Piridyl-naphthalene derivatives, process for the preparation thereof, and intermediates thereof
HUP0104035A3 (en) Novel erythromycin derivatives, preparation method and use as medicines
HUP9800555A3 (en) 3,3-diphenylallylamine derivatives and process for their preparation
EP0599159A3 (de) a-L-Rhamnosidase zur Gewinnung von Rhamnose, ein Verfahren zur Herstellung und ihre Verwendung.
HUP9600665A2 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
GB9310075D0 (en) New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
HUP9903424A3 (en) Novel erythromycin derivatives,method for preparing same and use thereof as drugs
HRP931016A2 (en) Thienothiazin derivatives, process for the preparation and application thereof
IL130420A (en) Erythromycin derivatives, method for preparing them and their use as medicine
GR3035834T3 (en) Benzoxazindione derivatives, process for their preparation and their use
HRP930131A2 (en) Amino-ascorbic acid derivatives, process for the preparation and use thereof
ZA9810403B (en) New epothilon derivatives, process for their preparation and their pharmaceutical use.
AU3218195A (en) Alpha-d-pentofuranoside derivatives, process for preparing the same and their use
HU9501546D0 (en) Sulphamide-derivatives, process for their preparation and their use as insecticides
HUP0103997A3 (en) Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines
ZA9610708B (en) Oxaindene derivatives and process for the preparation thereof.
HU9701216D0 (en) New nitropyrazolester derivatives, process for their preparation and their use
SI0794184T1 (en) 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same
SI1165596T1 (en) 14,15-alpha-methylene equilenine derivatives, methods for producing the same and medicaments containing them

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: ROUSSEL UCLAF, FR

Owner name: HOECHST MARION ROUSSEL, FR

Owner name: AVENTIS PHARMA S.A., FR

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20140311

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20150407